Cover Image
市場調查報告書

中國的癌症診察市場:診察數量、死亡率分析、預測 2022年

China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022

出版商 Renub Research 商品編碼 549937
出版日期 內容資訊 英文 357 Pages; 314 Figures; 12 Tables
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的癌症診察市場:診察數量、死亡率分析、預測 2022年 China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022
出版日期: 2017年08月29日 內容資訊: 英文 357 Pages; 314 Figures; 12 Tables
簡介

中國的癌症診察市場規模,預計至2022年末超過240億美元。

本報告提供中國的癌症診察市場相關調查,市場整體診察數量與預測,男女、各癌症類型的診察數量、死亡人數、死亡率的預測等。

第1章 調查結果

第2章 中國:癌症診察市場

  • 男性:癌症診察市場、預測
  • 女性:癌症診察市場、預測

第3章 中國:癌症診察數量

  • 男性:癌症診察數量、預測
  • 女性:癌症診察數量、預測

第4章 中國:癌症診察市場佔有率

  • 男性:癌症診察市場佔有率、預測
  • 女性:癌症診察市場佔有率、預測

第5章 中國:癌症診察市場佔有率 - 男性 vs. 女性

第6章 中國:癌症診察數量佔有率

  • 男性:癌症診察數量佔有率、預測
  • 女性:癌症診察數量佔有率、預測

第7章 中國的癌症診察數量佔有率 - 男性 vs. 女性

第8章 中國的癌症診察市場

  • 唇、口腔、咽 (鼻咽部除外) 癌症診察市場、預測
  • 鼻子咽喉癌診察市場、預測
  • 食道癌診察市場、預測
  • 胃癌診察市場、預測
  • 大腸癌診察市場、預測
  • 肝癌診察市場、預測
  • 膽囊癌診察市場、預測
  • 胰臟癌診察市場、預測
  • 喉癌診察市場、預測
  • 肺癌診察市場、預測
  • 其他胸廓器官癌症診察市場、預測
  • 骨癌診察市場、預測
  • 黑色素瘤皮膚癌診察市場、預測
  • 脖子癌症診察市場、預測
  • 子宮癌診察市場、預測
  • 卵巢癌診察市場、預測
  • 前列腺癌診察市場、預測
  • 睪丸癌診察市場、預測
  • 肝癌診察市場、預測
  • 膀胱癌診察市場、預測
  • 腦,CNS腫瘤診察市場、預測
  • 甲狀腺癌診察市場、預測
  • 淋巴瘤診察市場、預測
  • 白血病診察市場、預測
  • 其他、非特定診察市場

第9章 中國:癌症診察數量

第10章 中國:癌症死亡人數

第11章 癌症死亡率

第12章 中國的醫療制度、醫療費償付

第13章 附錄

圖表

目錄

As per Renub Research analysis China Cancer Test Market is projected to cross US$ 24 Billion by the end of 2022 . In China, cancer cases are rising and are one of the major causes of deaths in urban and rural areas. In order to mitigate cancer prevalence in China; the government focuses on several Cancer Control Programs which include prevention, early diagnosis and treatment. Early diagnosis programs include screening for breast and cervix cancer while prevention programs such as anti-smoking campaigns and immunization against hepatitis. Public awareness against cancer and the promotion of healthy lifestyle have also been carried out actively.

Growing Lung Cancer out of 26 Cancer Cases Studied in the Report

Cancer is one of the most significant public health burdens in China. China has exceptional number of lung cancer diagnoses and deaths than any other part of the world. The problem will keep mounting in near future as China' air pollution goes mostly unchecked. In total 26 types of Cancer market and number of cases have been studied in the report.

Lung Cancer dominates the China Oncology (Cancer) Screening Tests Market and Volume

In Male : Lung Cancer is the most predominant cancer, followed by Colorectal Cancer, Liver Cancer, Brain, CNS, Esophageal Cancer and Breast Cancer (not in same chorological order).

In Female : Other than Lung, Liver and Breast Cancer, Uterus and Ovarian Cancer are other most common cancers. Some other Cancers studied in this report are Lip, Oral Cavity, & Pharynx, Nasopharynx, Pancreas, Bone, Prostate, Luekemia, Bladder, Kidney and Lymphoma.

High Cancer Mortality Rates

Cancer mortality rates in China have been rising rapidly over the past three decades. In urban region, the mortality of cancer is comparatively higher than in rural one. Out of 26 Types of Cancer studied in the report, Lung cancer accounts for the highest fatalities, followed by Digestive Tract Cancers (Stomach, Liver Cancer, Esophageal and Colorectum Cancer).

Renub Research report titled "China Cancer Test Market, Volume, Forecast (By Male & Female), Mortality & 26 Cancer (Oncology) Types Market & Volume to 2022 " studies the oncology market in China. This 357 page report with 314 Figures and 12 Tables provides in-depth analysis of China Cancer Tests Market and Volume. All 26 types of cancer in the report have been analyzed from 3 major viewpoints which further study it from 2 different perspectives.

1. China Cancer (Oncology) Screening Tests Market & Forecast

  • Male
  • Female

2. China Cancer (Oncology) Screening Tests Volume & Forecast

  • Male
  • Female

3. China Cancer (Oncology) Mortality Rate

All the 26 Cancer Market & Cases Studied in the Report are as Follows:

  • 1. Lip, oral cavity, & pharynx (except nasopharynx)
  • 2. Nasopharynx
  • 3. Esophagus
  • 4. Stomach
  • 5. Colorectum
  • 6. Liver
  • 7. Gallbladder
  • 8. Pancreas
  • 9. Larynx
  • 10. Lung
  • 11. Other thoracic organs
  • 12. Bone
  • 13. Melanoma of the skin
  • 14. Breast
  • 15. Cervix
  • 16. Uterus
  • 17. Ovary
  • 18. Prostate
  • 19. Testis
  • 20. Kidney
  • 21. Bladder
  • 22. Brain, CNS
  • 23. Thyroid
  • 24. Lymphoma
  • 25. Leukemia
  • 26. All other sites and unspecified

Table of Contents

1. Research Findings

2. China - Cancer Test Market (2010 - 2022)

  • 2.1 Male - Cancer Test Market & Forecast
  • 2.2 Female - Cancer Test Market & Forecast

3. China - Cancer Test Volume (2010 - 2022)

  • 3.1 Male - Cancer Test Volume & Forecast
  • 3.2 Female - Cancer Test Volume & Forecast

4. China - Cancer Test Market Share (2010 - 2022)

  • 4.1 Male - Cancer Test Market Share & Forecast
  • 4.2 Female - Cancer Test Market Share & Forecast

5. China Oncology Test Market Share - Male Vs Female

6. China - Cancer Test Volume Share (2010 - 2022)

  • 6.1 Male - Cancer Test Volume Share & Forecast
  • 6.2 Female - Cancer Test Volume Share & Forecast

7. China Oncology Test Volume Share - Male Vs Female

8. China - Cancer Test Market (2010 - 2022)

  • 8.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market & Forecast
    • 8.1.1 Male - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market
    • 8.1.2 Female - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Market
  • 8.2 Nasopharynx Cancer Test Market & Forecast
    • 8.2.1 Male - Nasopharynx Cancer Test Market
    • 8.2.2 Female - Nasopharynx Cancer Test Market
  • 8.3 Esophagus Cancer Test Market & Forecast
    • 8.3.1 Male - Esophagus Cancer Test Market
    • 8.3.2 Female - Esophagus Cancer Test Market
  • 8.4 Stomach Cancer Test Market & Forecast
    • 8.4.1 Male - Stomach Cancer Test Market
    • 8.4.2 Female - Stomach Cancer Test Market
  • 8.5 Colorectum Cancer Test Market
    • 8.5.1 Male - Colorectum Cancer Test Market
    • 8.5.2 Female - Colorectum Cancer Test Market
  • 8.6 Liver Cancer Test Market & Forecast
    • 8.6.1 Male - Liver Cancer Test Market
    • 8.6.2 Female - Liver Cancer Test Market
  • 8.7 Gallbladder Cancer Test Market & Forecast
    • 8.7.1 Male - Gallbladder Cancer Test Market
    • 8.7.2 Female - Gallbladder Cancer Test Market
  • 8.8 Pancreas Cancer Test Market & Forecast
    • 8.8.1 Male - Pancreas Cancer Test Market
    • 8.8.2 Female - Pancreas Cancer Test Market
  • 8.9 Larynx Cancer Test Market & Forecast
    • 8.9.1 Male - Larynx Cancer Test Market
    • 8.9.2 Female - Larynx Cancer Test Market
  • 8.10 Lung Cancer Test Market & Forecast
    • 8.10.1 Male - Lung Cancer Test Market
    • 8.10.2 Female - Lung Cancer Test Market
  • 8.11 Other Thoracic Organs Cancer Test Market & Forecast
    • 8.11.1 Male - Other Thoracic Organs Cancer Test Market
    • 8.11.2 Female - Other Thoracic Organs Cancer Test Market
  • 8.12 Bone Cancer Test Market & Forecast
    • 8.12.1 Male - Bone Cancer Test Market
    • 8.12.2 Female - Bone Cancer Test Market
  • 8.13 Melanoma Skin Cancer Test Market & Forecast
    • 8.13.1 Male - Melanoma Skin Cancer Test Market
    • 8.13.2 Female - Melanoma Skin Cancer Test Market
  • 8.14 Breast Cancer Test Market & Forecast
    • 8.14.1 Male - Breast Cancer Test Market
    • 8.14.2 Female - Breast Cancer Test Market
  • 8.15 Cervix Cancer Test Market & Forecast
  • 8.16 Uterus Cancer Test Market & Forecast
  • 8.17 Ovary Cancer Test Market & Forecast
  • 8.18 Prostate Cancer Test Market & Forecast
  • 8.19 Testis Cancer Test Market
  • 8.20 Kidney Cancer Test Market & Forecast
    • 8.20.1 Male - Kidney Cancer Test Market
    • 8.20.2 Female - Kidney Cancer Test Market
  • 8.21 Bladder Cancer Test Market & Forecast
    • 8.21.1 Male - Bladder Cancer Test Market
    • 8.21.2 Female - Bladder Test Market
  • 8.22 Brain, CNS Cancer Test Market & Forecast
    • 8.22.1 Male - Brain, CNS Cancer Test Market
    • 8.22.2 Female - Brain, CNS Cancer Test Market
  • 8.23 Thyroid Cancer Test Market & Forecast
    • 8.23.1 Male - Thyroid Cancer Test Market
    • 8.23.2 Female - Thyroid Cancer Test Market
  • 8.24 Lymphoma Cancer Test Market
    • 8.24.1 Male - Lymphoma Cancer Test Market
    • 8.24.2 Female - Lymphoma Cancer Test Market
  • 8.25 Leukemia Cancer Test Market
    • 8.25.1 Male - Leukemia Cancer Test Market
    • 8.25.2 Female - Leukemia Cancer Test Market
  • 8.26 All Other and Unspecified Test Market
    • 8.26.1 Male - All Other and Unspecified Cancer Test Market
    • 8.26.2 Female - All Other and Unspecified Cancer Test Market

9. China - Oncology Test Volume (2010 - 2022)

  • 9.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume
    • 9.1.1 Male - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume
    • 9.1.2 Female - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume
  • 9.2 Nasopharynx Cancer Test Volume
    • 9.2.1 Male - Nasopharynx Cancer Test Volume
    • 9.2.2 Female - Nasopharynx Cancer Test Volume
  • 9.3 Esophagus Cancer Test Volume
    • 9.3.1 Male - Esophagus Cancer Test Volume
    • 9.3.2 Female - Esophagus Cancer Test Volume
  • 9.4 Stomach Cancer Test Volume
    • 9.4.1 Male - Stomach Cancer Test Volume
    • 9.4.2 Female - Stomach Cancer Test Volume
  • 9.5 Colorectum Cancer Test Volume
    • 9.5.1 Male - Colorectum Cancer Test Volume
    • 9.5.2 Female - Colorectum Cancer Test Volume
  • 9.6 Liver Cancer Test Volume
    • 9.6.1 Male - Liver Cancer Test Volume
    • 9.6.2 Female - Liver Cancer Test Volume
  • 9.7 Gallbladder Cancer Test Volume
    • 9.7.1 Male - Gallbladder Cancer Test Volume
    • 9.7.2 Female - Gallbladder Cancer Test Volume
  • 9.8 Pancreas Cancer Test Volume
    • 9.8.1 Male - Pancreas Cancer Test Volume
    • 9.8.2 Female - Pancreas Cancer Test Volume
  • 9.9 Larynx Cancer Test Volume
    • 9.9.1 Male - Larynx Cancer Test Volume
    • 9.9.2 Female - Larynx Cancer Test Volume
  • 9.10 Lung Cancer Test Volume
    • 9.10.1 Male - Lung Cancer Test Volume
    • 9.10.2 Female - Lung Cancer Test Volume
  • 9.11 Other Thoracic Organs Test Volume
    • 9.11.1 Male - Other Thoracic Organs Cancer Test Volume
    • 9.11.2 Female - Other Thoracic Organs Cancer Test Volume
  • 9.12 Bone Cancer Test Volume
    • 9.12.1 Male - Bone Cancer Test Volume
    • 9.12.2 Female - Bone Cancer Test Volume
  • 9.13 Melanoma of the Skin Cancer Test Volume
    • 9.13.1 Male - Melanoma of the Skin Cancer Test Volume
    • 9.13.2 Female - Melanoma of the Skin Cancer Test Volume
  • 9.14 Breast Cancer Test Volume
    • 9.14.1 Male - Breast Cancer Test Volume
    • 9.14.2 Female - Breast Cancer Test Volume
  • 9.15 Cervix Cancer Test Volume
  • 9.16 Uterus Cancer Test Volume
  • 9.17 Ovary Cancer Test Volume
  • 9.18 Prostate Cancer Test Volume
  • 9.19 Testis Cancer Test Volume
  • 9.20 Kidney Cancer Test Volume
    • 9.20.1 Male - Kidney Cancer Test Volume
    • 9.20.2 Female - Kidney Cancer Test Volume
  • 9.21 Bladder Cancer Test Volume
    • 9.21.1 Male - Bladder Cancer Test Volume
    • 9.21.2 Female - Bladder Cancer Test Volume
  • 9.22 Brain, CNS Cancer Test Volume
    • 9.22.1 Male - Brain, CNS Cancer Test Volume
    • 9.22.2 Female - Brain, CNS Cancer Test Volume
  • 9.23 Thyroid Cancer Test Volume
    • 9.23.1 Male - Thyroid Cancer Test Volume
    • 9.23.2 Female - Thyroid Cancer Test Volume
  • 9.24 Lymphoma Cancer Test Volume
    • 9.24.1 Male - Lymphoma Cancer Test Volume
    • 9.24.2 Female - Lymphoma Cancer Test Volume
  • 9.25 Leukemia Cancer Test Volume
    • 9.25.1 Male - Leukemia Cancer Test Volume
    • 9.25.2 Female - Leukemia Cancer Test Volume
  • 9.26 All Other and Unspecified Test Volume
    • 9.26.1 Male - All Other and Unspecified Cancer Test Volume
    • 9.26.2 Female - All Other and Unspecified Cancer Test Volume

10. China - Cancer Deaths (2010 - 2022)

11. China - Cancer Mortality Rate (2015)

  • 11.1 Lip, Oral Cavity, & Pharynx (except Nasopharynx)
  • 11.2 Nasopharynx
  • 11.3 Esophagus
  • 11.4 Stomach
  • 11.5 Colorectum
  • 11.6 Liver
  • 11.7 Gallbladder
  • 11.8 Pancreas
  • 11.9 Larynx
  • 11.10 Lung
  • 11.11 Other Thoracic Organs
  • 11.12 Bone
  • 11.13 Melanoma of the skin
  • 11.14 Breast
  • 11.15 Cervix
  • 11.16 Uterus
  • 11.17 Ovary
  • 11.18 Prostate
  • 11.19 Testis
  • 11.20 Kidney
  • 11.21 Bladder
  • 11.22 Brain, CNS
  • 11.23 Thyroid
  • 11.24 Lymphoma
  • 11.25 Leukemia
  • 11.26 All Other and Unspecified

12. China Healthcare Policies and Reimbursement

  • 12.1 The Healthcare Policies
  • 12.2 China Healthcare Insurance Schemes
    • 12.2.1 NRCMS
    • 12.2.2 UEBMI
    • 12.2.3 URBMI
    • 12.2.4 Private Health Insurance

13. Appendix

List of Figures

  • Figure 2-1: China - Cancer Test Market (Billion US$), 2010 - 2016
  • Figure 2-2: China - Forecast for Oncology Test Market (Billion US$), 2017 - 2022
  • Figure 2-3: China - Cancer (Male) Test Market (Billion US$), 2010 - 2016
  • Figure 2-4: China - Forecast for Cancer (Male) Test Market (Billion US$), 2017 - 2022
  • Figure 2-5: China - Cancer (Female) Test Market (Billion US$), 2010 - 2016
  • Figure 2-6: China - Forecast for Cancer (Female) Test Market (Billion US$), 2017 - 2022
  • Figure 3-1: China - Cancer Test Volume (Million), 2010 - 2016
  • Figure 3-2: China - Forecast for Cancer Test Volume (Million), 2017 - 2022
  • Figure 3-3: China - Oncology (Male) Test Volume (Million), 2010 - 2016
  • Figure 3-4: China - Forecast for Oncology (Male) Test Volume (Million), 2017 - 2022
  • Figure 3-5: China - Oncology (Female) Test Volume (Million), 2010 - 2016
  • Figure 3-6: China - Forecast for Oncology (Female) Test Volume (Million), 2017 - 2022
  • Figure 5-1: China Cancer Test Market Share (%) - Male Vs Female, 2016 - 2022
  • Figure 7-1: China Cancer Test Volume Share (%) - Male Vs Female, 2016 - 2022
  • Figure 8-1: China - Lip, oral cavity, & pharynx (except nasopharynx) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-2: China - Forecast for Lip, oral cavity, & pharynx (except nasopharynx) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-3: China - Lip, oral cavity, & pharynx (except nasopharynx) (Male) Test Market (Million US$), 2010 - 2016
  • Figure 8-4: China - Forecast for Lip, oral cavity, & pharynx (except nasopharynx) (Male) Test Market (Million US$), 2017 - 2022
  • Figure 8-5: China - Lip, Oral Cavity, & Pharynx (except Nasopharynx) (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-6: China - Forecast for Lip, oral cavity, & pharynx (except nasopharynx) (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-7: China - Nasopharynx Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-8: China - Forecast for Nasopharynx Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-9: China - Nasopharynx (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-10: China - Forecast for Nasopharynx (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-11: China - Nasopharynx (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-12: China - Forecast for Nasopharynx (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-13: China - Esophagus Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-14: China - Forecast for Esophagus Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-15: China - Esophagus (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-16: China - Forecast for Esophagus (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-17: China - Esophagus (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-18: China - Forecast For Esophagus (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-19: China - Stomach Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-20: China - Forecast for Stomach Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-21: China - Stomach (Male) Test Market (Million US$), 2010 - 2016
  • Figure 8-22: China - Forecast for Stomach (Male) Test Market (Million US$), 2017 - 2022
  • Figure 8-23: China - Stomach (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-24: China - Forecast for Stomach (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-25: China - Colorectum Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-26: China - Forecast for Colorectum Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-27: China - Colorectum (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-28: China - Forecast for Colorectum (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-29: China - Colorectum (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-30: China - Forecast for Colorectum (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-31: China - Liver Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-32: China - Forecast for Liver Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-33: China - Liver (Male) Test Market (Million US$), 2010 - 2016
  • Figure 8-34: China - Forecast for Liver (Male) Test Market (Million US$), 2017 - 2022
  • Figure 8-35: China - Liver (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-36: China - Forecast for Liver (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-37: China - Gallbladder Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-38: China - Forecast for Gallbladder Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-39: China - Gallbladder (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-40: China - Forecast for Gallbladder (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-41: China - Gallbladder (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-42: China - Forecast for Gallbladder (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-43: China - Pancreas Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-44: China - Forecast for Pancreas Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-45: China - Pancreas (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-46: China - Forecast for Pancreas (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-47: China - Pancreas (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-48: China - Forecast for Pancreas (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-49: China - Larynx Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-50: China - Forecast for Larynx Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-51: China - Larynx (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-52: China - Forecast for Larynx (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-53: China - Larynx (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-54: China - Forecast for Larynx (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-55: China - Lung Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-56: China - Forecast for Lung Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-57: China - Lung (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-58: China - Forecast for Lung (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-59: China - Lung (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-60: China - Forecast for Lung (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-61: China - Other Thoracic Organs Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-62: China - Forecast for Other Thoracic Organs Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-63: China - Other Thoracic Organs (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-64: China - Forecast for Other Thoracic Organs (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-65: China - Other thoracic organs (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-66: China - Forecast for Other thoracic organs (Female) Test Market (Million US$), 2017 - 2022
  • Figure 8-67: China - Bone Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-68: China - Forecast for Bone Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-69: China - Bone (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-70: China - Forecast for Bone (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-71: China - Bone (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-72: China - Forecast for Bone (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-73: China - Melanoma of the Skin Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-74: China - Forecast for Melanoma of the Skin Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-75: China - Melanoma Skin Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-76: China - Forecast for Melanoma Skin Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-77: China - Melanoma Skin (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-78: China - Forecast for Melanoma of Skin (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-79: China - Breast Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-80: China - Forecast for Breast Test Market (Million US$), 2017 - 2022
  • Figure 8-81: China - Breast (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-82: China - Forecast for Breast (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-83: China - Breast (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-84: China - Forecast for Breast (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-85: China - Cervix Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-86: China - Forecast for Cervix Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-87: China - Uterus Test Market (Million US$), 2010 - 2016
  • Figure 8-88: China - Forecast for Uterus Test Market (Million US$), 2017 - 2022
  • Figure 8-89: China - Ovary Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-90: China - Forecast for Ovary Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-91: China - Prostate Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-92: China - Forecast for Prostate Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-93: China - Testis Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-94: China - Forecast for Testis Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-95: China - Kidney Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-96: China - Forecast for Kidney Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-97: China - Kidney (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-98: China - Forecast for Kidney (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-99: China - Kidney (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-100: China - Forecast for Kidney (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-101: China - Bladder Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-102: China - Forecast for Bladder Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-103: China - Bladder (Male) Test Market (Million US$), 2010 - 2016
  • Figure 8-104: China - Forecast for Bladder (Male) Test Market (Million US$), 2017 - 2022
  • Figure 8-105: China - Bladder (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-106: China - Forecast for Bladder (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-107: China - Brain, CNS Test Market (Million US$), 2010 - 2016
  • Figure 8-108: China - Forecast for Brain, CNS Test Market (Million US$), 2017 - 2022
  • Figure 8-109: China - Brain, CNS (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-110: China - Forecast for Brain, CNS (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-111: China - Brain, CNS (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-112: China - Forecast for Brain, CNS (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-113: China - Thyroid Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-114: China - Forecast for Thyroid Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-115: China - Thyroid (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-116: China - Forecast for Thyroid (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-117: China - Thyroid (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-118: China - Forecast for Thyroid (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-119: China - Lymphoma Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-120: China - Forecast for Lymphoma Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-121: China - Lymphoma (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-122: China - Forecast for Lymphoma (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-123: China - Lymphoma (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-124: China - Forecast for Lymphoma (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-125: China - Leukemia Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-126: China - Forecast for Leukemia Test Market (Million US$), 2017 - 2022
  • Figure 8-127: China - Leukemia (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-128: China - Forecast for Leukemia (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-129: China - Leukemia (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-130: China - Forecast for Leukemia (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-131: China - All Other and Unspecified Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-132: China - Forecast for All Other and Unspecified Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-133: China - All Other and Unspecified (Male) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-134: China - Forecast for All Other and Unspecified (Male) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 8-135: China - All Other and Unspecified (Female) Cancer Test Market (Million US$), 2010 - 2016
  • Figure 8-136: China - Forecast for All Other and Unspecified (Female) Cancer Test Market (Million US$), 2017 - 2022
  • Figure 9-1: China - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-2: China - Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-3: China - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-4: China - Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-5: China - Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-6: China - Forecast for Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-7: China - Nasopharynx Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-8: China - Forecast for Nasopharynx Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-9: China - Nasopharynx (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-10: China - Forecast for Nasopharynx (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-11: China - Nasopharynx (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-12: China - Forecast for Nasopharynx (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-13: China - Esophagus Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-14: China - Forecast for Esophagus Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-15: China - Esophagus (Male) Cancer Test Volume (Thousand), 2010 -2016
  • Figure 9-16: China - Forecast for Esophagus (Male) Cancer Test Volume (Thousand), 2017 -2022
  • Figure 9-17: China - Esophagus (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-18: China - Forecast for Esophagus (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-19: China - Stomach Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-20: China - Forecast for Stomach Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-21: China - Stomach (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-22: China - Forecast for Stomach (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-23: China - Stomach (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-24: China - Stomach (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-25: China - Colorectum Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-26: China - Forecast for Colorectum Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-27: China - Colorectum (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-28: China - Forecast for Colorectum (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-29: China - Colorectum (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-30: China - Forecast for Colorectum (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-31: China - Liver Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-32: China - Forecast for Liver Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-33: China - Liver (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-34: China - Forecast for Liver (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-35: China - Liver (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-36: China - Forecast for Liver (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-37: China - Gallbladder Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-38: China - Forecast for Gallbladder Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-39: China - Gallbladder (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-40: China - Forecast for Gallbladder (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-41: China - Gallbladder (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-42: China - Forecast for Gallbladder (Female) Test Volume (Thousand), 2017 - 2022
  • Figure 9-43: China - Pancreas Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-44: China - Forecast for Pancreas Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-45: China - Pancreas (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-46: China - Forecast for Pancreas (Male) Test Volume (Thousand), 2017 - 2022
  • Figure 9-47: China - Pancreas (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-48: China - Forecast for Pancreas (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-49: China - Larynx Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-50: China - Forecast for Larynx Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-51: China - Larynx (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-52: China - Forecast for Larynx (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-53: China - Larynx (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-54: China - Forecast for Larynx (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-55: China - Lung Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-56: China - Forecast for Lung Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-57: China - Lung (Male) Cacner Test Volume (Thousand), 2010 - 2016
  • Figure 9-58: China - Forecast for Lung (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-59: China - Lung (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-60: China - Forecast for Lung (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-61: China - Other Thoracic Organs Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-62: China - Forecast for Other Thoracic Organs Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-63: China - Other Thoracic Organs (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-64: China - Forecast for Other Thoracic Organs (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-65: China - Other Thoracic Organs (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-66: China - Forecast for Other thoracic organs (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-67: China - Bone Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-68: China - Forecast for Bone Test Volume (Thousand), 2017 - 2022
  • Figure 9-69: China - Bone (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-70: China - Forecast for Bone (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-71: China - Bone (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-72: China - Forecast for Bone (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-73: China - Melanoma of the Skin Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-74: China - Forecast for Melanoma of the Skin Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-75: China - Melanoma of the Skin (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-76: China - Forecast for Melanoma of the skin (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-77: China - Melanoma of the Skin (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-78: China - Melanoma of the Skin (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-79: China - Breast Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-80: China - Forecast for Breast Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-81: China - Breast (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-82: China - Forecast for Breast (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-83: China - Breast (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-84: China - Forecast for Breast (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-85: China - Cervix Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-86: China - Forecast for Cervix Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-87: China - Uterus Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-88: China - Forecast for Uterus Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-89: China - Ovary Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-90: China - Forecast for Ovary Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-91: China - Prostate Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-92: China - Forecast for Prostate Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-93: China - Testis Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-94: China - Forecast for Testis Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-95: China - Kidney Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-96: China - Forecast for Kidney Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-97: China - Kidney (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-98: China - Forecast for Kidney (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-99: China - Kidney (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-100: China - Forecast for Kidney (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-101: China - Bladder Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-102: China - Forecast for Bladder Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-103: China - Bladder (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-104: China - Forecast for Bladder (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-105: China - Bladder (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-106: China - Forecast for Bladder (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-107: China - Brain, CNS Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-108: China - Forecast for Brain, CNS Test Volume (Thousand), 2017 - 2022
  • Figure 9-109: China - Brain, CNS (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-110: China - Forecast for Brain, CNS (Male) Test Volume (thousand), 2017 - 2022
  • Figure 9-111: China - Brain, CNS (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-112: China - Forecast for Brain, CNS (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-113: China - Thyroid Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-114: China - Forecast for Thyroid Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-115: China - Thyroid (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-116: China - Forecast for Thyroid (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-117: China - Thyroid (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-118: China - Forecast for Thyroid (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-119: China - Lymphoma Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-120: China - Forecast for Lymphoma Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-121: China - Lymphoma (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-122: China - Forecast for Lymphoma (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-123: China - Lymphoma (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-124: China - Forecast for Lymphoma (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-125: China - Leukemia Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-126: China - Forecast for Leukemia Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-127: China - Leukemia (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-128: China - Forecast for Leukemia (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-129: China - Leukemia (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-130: China - Forecast for Leukemia (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-131: China - All Other and Unspecified Caner Test Volume (Thousand), 2010 - 2016
  • Figure 9-132: China - Forecast for All Other and Unspecified Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-133: China - All Other and Unspecified (Male) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-134: China - Forecast for All Other and Unspecified (Male) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 9-135: China - All other and unspecified (Female) Cancer Test Volume (Thousand), 2010 - 2016
  • Figure 9-136: China - Forecast for All Other and Unspecified (Female) Cancer Test Volume (Thousand), 2017 - 2022
  • Figure 10-1: China - Cancer Deaths (Million), 2010 - 2016
  • Figure 10-2: China - Estimation for Cancer Deaths (Million), 2017 - 2022
  • Figure 11-1: Lip, Oral Cavity, & Pharynx (except Nasopharynx) Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-2: Nasopharynx Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-3: Esophagus Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-4: Stomach Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-5: Colorectum Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-6: Liver Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-7: Gallbladder Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-8: Pancreas Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-9: Larynx Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-10: Lung Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-11: Other Thoracic Organs Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-12: Bone Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-13: Melanoma of the skin Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-14: Breast Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-15: Cervix Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-16: Uterus Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-17: Ovary Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-18: Prostate Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-19: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-20: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-21: Testis Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-22: Brain, CNS Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-23: Thyroid Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-24: Lymphoma Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-25: Leukemia Cancer Mortality Rate (Thousand) By Sex, 2015
  • Figure 11-26: All other and unspecified Cancer Mortality Rate (Thousand) By Sex, 2015

List of Tables

  • Table 4-1: China - Cancer Test Market Share (%), 2010 - 2016
  • Table 4-2: China - Forecast for Cancer Test Market Share (%), 2017 - 2022
  • Table 4-3: China - Oncology (Male) Test Market Share (%), 2010 - 2016
  • Table 4-4: China - Forecast for Oncology (Male) Test Market Share (%), 2017 - 2022
  • Table 4-5: China - Cancer (Female) Test Market Share (%), 2010 - 2016
  • Table 4-6: China - Forecast for Cancer (Female) Test Market Share (%), 2017 - 2022
  • Table 6-1: China - Cancer Test Volume Share (%), 2010 - 2016
  • Table 6-2: China - Forecast for Cancer Test Volume Share (%), 2017 - 2022
  • Table 6-3: China - Cancer (Male) Test Volume Share (%), 2010 - 2016
  • Table 6-4: China - Forecast for Cancer (Male) Test Volume Share (%), 2017 - 2022
  • Table 6-5: China - Cancer (Female) Test Volume Share (%), 2010 - 2016
  • Table 6-6: China - Forecast for Cancer (Female) Test Volume Share (%), 2017 - 2022
Back to Top